Informing immunisation policy for meningitis vaccines in UK and Africa using mathematical models

Add to your list(s) Download to your calendar using vCal

• Dr Caroline Trotter, Department of Veterinary Medicine, University of Cambridge
• Wednesday 23 November 2016, 16:00-17:00
• Lecture Theatre 2, Department of Veterinary Medicine.

If you have a question about this talk, please contact Fiona Roby.

Meningococcal disease, caused by the bacterium Neisseria meningitidis is an important public health problem worldwide, though incidence and epidemiology varies greatly by geography. The African meningitis belt, stretching from Senegal in the West to Ethiopia in the east experiences by far the highest burden of disease, with epidemics occurring periodically, though irregularly in the dry season. In the UK meningococcal disease is relatively rare, with incidence currently around 2 per 100,000, although is still much feared by parents. Vaccines are now available against nearly all of the disease causing strains. During this talk I will compare and contrast the epidemiology of meningococcal infection in Africa and the UK and discuss challenges to vaccine development and implementation. I will describe my research into the predicted and actual impact of MenAfriVac® a group A conjugate vaccine used in the meningitis belt, and Bexsero® a vaccine designed to protect against group B disease in the UK.

This talk is part of the Departmental Seminar Programme, Department of Veterinary Medicine series.

This talk is included in these lists:

• All Talks (aka the CURE list)
• Cambridge Immunology
• Cambridge Infectious Disease
• Cambridge Infectious Diseases
• Departmental Seminar Programme, Department of Veterinary Medicine
• Lecture Theatre 2, Department of Veterinary Medicine
• Vet School Seminars

Note that ex-directory lists are not shown.